In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.
The study, led by TSRI Associate Professor Susana Valente, was published online Oct. 17 before print in the journal Cell Reports.
“No other anti-retroviral used in the clinic today is able to completely suppress viral production in infected cells in vivo,” Valente said. “When combining this drug with the standard cocktail of anti-retrovirals used to suppress infection in humanized mouse models of HIV-1 infection, our study found a drastic reduction in virus RNA present—it is really the proof-of-concept for a ‘functional cure.’”
Valente, a pioneer in this new approach, calls it “Block-and-Lock”—the approach blocks reactivation of the virus in cells, even during treatment interruptions, and locks HIV into durable state of latency.
Valente and her colleagues use a derivative of a natural compound called didehydro-Cortistatin A (dCA), which blocks replication in HIV-infected cells by inhibiting the viral transcriptional activator, called Tat, halting viral production, reactivation and replenishment of the latent viral reservoir.
“Combining dCA with anti-retroviral therapy accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation,” Valente said. “It’s important to note that our study uses the maximum tolerable dose of the drug—with virtually no side effects.”
The scientists studied the combination therapy in a mouse model of HIV latency and persistence. Once the combined treatment regimen was halted, viral rebound was delayed up to 19 days, compared with just seven days in mouse models receiving only anti-retroviral treatment.
“This demonstrates the potential of ‘block-and-lock’ strategies,” said TSRI Research Associate Cari F. Kessing, co-first author of the study. “This study shows that a ‘functional cure’ approach can succeed in reducing residual virus in the blood during anti-retroviral treatment and limiting viral rebound during treatment interruption.”
“In half of the dCA treated mice, the virus was undetectable for 16 days after all treatment was halted,” said the University of North Carolina’s Christopher Nixon, another first author.
“We blocked Tat, and the cell’s machinery did the rest,” said TSRI Research Associate Chuan Li, a coauthor of the study. “The result was that the HIV promoter becomes repressed.”
Valente pointed out that the animal models were exposed to just a single month of treatment. “That’s a relatively short period of time,” she said. “We think longer treatments will result in longer, or even permanent, rebound delays. The question is how long? We’re studying that now.”
Because any viral rebound of HIV comes with a host of adverse effects, Valente noted, blocking that rebound would automatically reduce those effects.
“This is the only class of drugs that stops infected cells from making viruses outright,” said Valente. “All current antivirals work later in the viral lifecycle, so only a HIV transcriptional inhibitor like dCA can stop the side effects of low-level virus production.”
The Latest on: HIV
Norwalk Health Department To Offer Free HIV Testing
on June 20, 2018 at 4:11 pm
From the Norwalk Health Department: The Norwalk Health Department will offer free rapid testing for human immunodeficiency virus (HIV) on June 27, National HIV Testing Day. Staff will provide testing from 9 am to 4:30 pm at the Health Department (137 East ... […]
Free HIV testing at Health Department on June 27
on June 20, 2018 at 3:50 pm
NORWALK — The Norwalk Health Department will offer free, rapid testing for human immunodeficiency virus June 27 as part of National HIV Testing Day. Staff will provide testing, from 9 a.m. to 4:30 p.m., at the department, 137 East Ave. No appointment is ... […]
She asked her boyfriend to get tested. He lied about his HIV — and his marriage, Houston cops say
on June 20, 2018 at 3:23 pm
There were a handful of clues that the Texas woman was seriously ill. She came down with pneumonia in May 2014, and it was severe enough she had to be hospitalized, according to a criminal complaint. A month earlier, she had started losing “considerable ... […]
Man awarded $18.4M in lawsuit over canceled HIV test
on June 20, 2018 at 1:11 pm
The Boston Globe reports the jury ruled Monday in favor of 48-year-old Sean Stentiford in his medical malpractice lawsuit against internist Stephen Southard and neurologist Kinan Hreib. Stentiford said he consented to an HIV test in 2007 because he was ... […]
Man awarded $18.4 million in lawsuit over failed HIV test
on June 20, 2018 at 9:14 am
BOSTON-- A federal jury has awarded $18.4 million in damages to a man who said in a lawsuit that two doctors failed to test him for HIV, which allowed the virus to progress to AIDS. The Boston Globe reports the jury ruled Monday in favor of 48-year-old ... […]
Glaxo Venture's Lofty Goal in HIV: Eclipse Gilead as Top Player
on June 20, 2018 at 6:51 am
GlaxoSmithKline Plc’s HIV venture wants to use less burdensome forms of treatment to unseat rival Gilead Sciences Inc. and become the top player in the $26 billion-a-year market in the mid-2020s. “If our pipeline and our competitors’ pipelines play ... […]
Reduction in HIV diagnoses in New Zealand
on June 20, 2018 at 5:03 am
Number of people diagnosed with HIV in New Zealand through Western Blot antibody test and since 2002 through viral load (VL) testing, by year of diagnosis and means of infection. It is important to appreciate that infection may have occurred a number of ... […]
High rates of HIV and diabetes raise the risk of TB for South Africans
on June 20, 2018 at 4:57 am
Since the 1980s, HIV has contributed to an increase in tuberculosis (TB) cases across the globe. Recently, diabetes has been found to be an important risk factor for TB. In a new study, Yale researchers investigated whether having both HIV and diabetes ... […]
Judge in Charlie Sheen HIV case slams slut-shaming but leans toward arbitration
on June 20, 2018 at 1:44 am
LOS ANGELES — An ex-girlfriend of Charlie Sheen who sued the actor alleging he exposed her to HIV and then discouraged her from taking the appropriate medication will have to take her case to arbitration, a judge said Tuesday in a tentative ruling. […]
Man awarded $18.4 million in lawsuit over canceled HIV test
on June 20, 2018 at 12:12 am
BOSTON (AP) — A federal jury has awarded $18.4 million in damages to a man who said in a lawsuit that two doctors failed to test him for HIV, which allowed the virus to progress to AIDS. The Boston Globe reports the jury ruled Monday in favor of 48-year ... […]
via Google News and Bing News